Heart valve development: endothelial cell signaling and differentiation.

During the past decade, single gene disruption in mice and large-scale mutagenesis screens in zebrafish have elucidated many fundamental genetic pathways that govern early heart patterning and differentiation. Specifically, a number of genes have been revealed serendipitously to play important and selective roles in cardiac valve development. These initially surprising results have now converged on a finite number of signaling pathways that regulate endothelial proliferation and differentiation in developing and postnatal heart valves. This review highlights the roles of the most well-established ligands and signaling pathways, including VEGF, NFATc1, Notch, Wnt/beta-catenin, BMP/TGF-beta, ErbB, and NF1/Ras. Based on the interactions among and relative timing of these pathways, a signaling network model for heart valve development is proposed.

[1]  D. Rimm,et al.  PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. , 1999, Journal of cell science.

[2]  J. R. Zuberbuhler,et al.  Prevalence of congenital cardiac anomalies at high altitude. , 1988, Journal of the American College of Cardiology.

[3]  N. Copeland,et al.  Erratum: Targeted disruption of the neurofibromatosis type 1 gene leads to developmental abnormalities of the heart and various neural crest-derived tissues (Genes and Development (1994) 8 (1019-1029)) , 1994 .

[4]  L. Gavin,et al.  Preconception care of diabetes. Glycemic control prevents congenital anomalies. , 1991, JAMA.

[5]  Tak W. Mak,et al.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.

[6]  R. Markwald,et al.  Genetic aspects of atrioventricular septal defects. , 2000, American journal of medical genetics.

[7]  K. Miyazono,et al.  Bone morphogenetic protein‐2 acts synergistically with transforming growth factor‐β3 during endothelial‐mesenchymal transformation in the developing chick heart , 1999, Journal of cellular physiology.

[8]  R. Markwald,et al.  Expression of smooth muscle alpha‐actin in mesenchymal cells during formation of avian endocardial cushion tissue: A role for transforming growth factor β3 , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  N. Copeland,et al.  The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. , 1994, Genes & development.

[10]  Raymond B. Runyan,et al.  Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. , 1983, Developmental biology.

[11]  R R Markwald,et al.  Molecular regulation of atrioventricular valvuloseptal morphogenesis. , 1995, Circulation research.

[12]  G. Frantz,et al.  ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. , 1997, Development.

[13]  J. McDonald,et al.  Hyaluronan: Genetic insights into the complex biology of a simple polysaccharide , 2002, Glycoconjugate Journal.

[14]  B. Hogan,et al.  Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). , 1990, Development.

[15]  Michael J. Grusby,et al.  The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.

[16]  M. Lardelli,et al.  Three novel Notch genes in zebrafish: implications for vertebrate Notch gene evolution and function , 1997, Development Genes and Evolution.

[17]  R. Behringer,et al.  Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. J. Day,et al.  Hyaluronan-binding Proteins: Tying Up the Giant* , 2002, The Journal of Biological Chemistry.

[19]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[20]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[21]  P. Carmeliet,et al.  A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. , 2001, Development.

[22]  熊井 まどか.  Loss of connexin45 causes a cushion defect in early cardiogenesis , 2000 .

[23]  Gabriel Acevedo-Bolton,et al.  Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis , 2003, Nature.

[24]  Rick B. Vega,et al.  A Protein Encoded within the Down Syndrome Critical Region Is Enriched in Striated Muscles and Inhibits Calcineurin Signaling* , 2000, The Journal of Biological Chemistry.

[25]  E. Carver,et al.  The Mouse Snail Gene Encodes a Key Regulator of the Epithelial-Mesenchymal Transition , 2001, Molecular and Cellular Biology.

[26]  Elazer R Edelman,et al.  Tissue Engineering Therapy for Cardiovascular Disease , 2003, Circulation research.

[27]  T. Magnuson,et al.  Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis , 2000, Nature Genetics.

[28]  M. Nieto,et al.  The snail superfamily of zinc-finger transcription factors , 2002, Nature Reviews Molecular Cell Biology.

[29]  Raymond B. Runyan,et al.  Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. , 2000, Developmental biology.

[30]  J. Epstein,et al.  Molecular markers of cardiac endocardial cushion development , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[31]  C. Ferencz.  Epidemiology of congenital heart disease : The Baltimore-Washington Infant Study 1981-1989 , 1993 .

[32]  R. Cripps,et al.  Control of cardiac development by an evolutionarily conserved transcriptional network. , 2002, Developmental biology.

[33]  J. Epstein,et al.  Nf1 has an essential role in endothelial cells , 2003, Nature Genetics.

[34]  E. Délot,et al.  Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. , 2003, Molecular genetics and metabolism.

[35]  G M Hutchins,et al.  The development of the semilunar valves in the human heart. , 1974, The American journal of pathology.

[36]  Michael A. Patton,et al.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome , 2001, Nature Genetics.

[37]  T. Camenisch,et al.  Elevated glucose inhibits VEGF-A–mediated endocardial cushion formation , 2003, The Journal of cell biology.

[38]  Lin Chen,et al.  Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.

[39]  B. Hogan,et al.  Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. , 1991, Development.

[40]  S. Hokari,et al.  Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: Roles of transforming growth factor (TGF)‐β and bone morphogenetic protein (BMP) , 2000, The Anatomical record.

[41]  K. Miyazono,et al.  Induction of Smad6 mRNA by bone morphogenetic proteins. , 1998, Biochemical and biophysical research communications.

[42]  M. Gimbrone,et al.  A role for Smad6 in development and homeostasis of the cardiovascular system , 2000, Nature Genetics.

[43]  J. Schmitt,et al.  A Murine Model of Holt-Oram Syndrome Defines Roles of the T-Box Transcription Factor Tbx5 in Cardiogenesis and Disease , 2001, Cell.

[44]  R. Markwald,et al.  Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. , 2004, Developmental biology.

[45]  A. Schier,et al.  Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. , 1996, Development.

[46]  D G Wilkinson,et al.  Control of cell behavior during vertebrate development by Slug, a zinc finger gene. , 1994, Science.

[47]  Katherine E Yutzey,et al.  Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. , 2004, Developmental biology.

[48]  X. Estivill,et al.  Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis , 2001, Mechanisms of Development.

[49]  Margaret Robertson,et al.  The neurofibromatosis type 1 gene encodes a protein related to GAP , 1990, Cell.

[50]  Y. Dor,et al.  VEGF modulates early heart valve formation. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[51]  N. Copeland,et al.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. , 1994, Genes & development.

[52]  A. Nagy,et al.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. , 2000, Development.

[53]  S. Klewer,et al.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.

[54]  R. Markwald,et al.  Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. , 1987, Developmental biology.

[55]  M. Khoury,et al.  Population-based study of congenital heart defects in Down syndrome. , 1998, American journal of medical genetics.

[56]  J. Pérez-Pomares,et al.  Immunolocalization of the transcription factor Slug in the developing avian heart , 2000, Anatomy and Embryology.

[57]  R. Markwald,et al.  Migratory behavior of cardiac cushion tissue cells in a collagen-lattice culture system. , 1982, Developmental biology.

[58]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.

[59]  I. Zachary,et al.  Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. , 2001, Cardiovascular research.

[60]  A. Moorman,et al.  The development of the atrioventricular junction in the human heart. , 1996, Circulation research.

[61]  K. Lyons,et al.  BMP signaling is required for septation of the outflow tract of the mammalian heart , 2003, Development.

[62]  D. Stainier,et al.  UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. , 2001, Science.

[63]  Rick B. Vega,et al.  Multiple Domains of MCIP1 Contribute to Inhibition of Calcineurin Activity* , 2002, The Journal of Biological Chemistry.

[64]  Frank McCormick,et al.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.

[65]  K. Cunningham,et al.  A conserved family of calcineurin regulators. , 2000, Genes & development.

[66]  Katherine E Yutzey,et al.  Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[67]  E. Olson,et al.  Independent Signals Control Expression of the Calcineurin Inhibitory Proteins MCIP1 and MCIP2 in Striated Muscles , 2000, Circulation research.

[68]  Arthur D. Lander,et al.  The Elusive Functions of Proteoglycans , 2000, The Journal of cell biology.

[69]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[70]  E. Cuppen,et al.  The Wnt/beta-catenin pathway regulates cardiac valve formation. , 2003, Nature.

[71]  David C. Lee,et al.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling , 2003, Journal of Molecular Medicine.

[72]  J A Epstein,et al.  Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. , 1998, Development.

[73]  M. Kirby,et al.  Neural crest cells contribute to normal aorticopulmonary septation. , 1983, Science.

[74]  N. W. Shworak,et al.  Angiogenic modulators in valve development and disease: does valvular disease recapitulate developmental signaling pathways? , 2004, Current opinion in cardiology.

[75]  R. Kim,et al.  Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. , 2001, Developmental biology.

[76]  Rüdiger Klein,et al.  Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor , 1995, Nature.

[77]  J. Rossant,et al.  Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. , 1999, Developmental biology.

[78]  G. Crabtree,et al.  NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.

[79]  J. Massagué,et al.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.

[80]  Lilly Y. W. Bourguignon,et al.  Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.

[81]  F. Schoen,et al.  Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. , 2001, The American journal of pathology.

[82]  E. Olson,et al.  Heart development: learning from mistakes. , 2002, Current opinion in genetics & development.

[83]  Robert H. Anderson,et al.  Development of the heart: (2) Septation of the atriums and ventricles , 2003, Heart.

[84]  S. Klewer,et al.  Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors , 2002, Nature Medicine.

[85]  C. Romano,et al.  Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. , 2000, American journal of medical genetics.

[86]  M. Goumans,et al.  Differential expression of BMP receptors in early mouse development. , 1997, The International journal of developmental biology.

[87]  L. Zon,et al.  Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects , 2003, Mechanisms of Development.

[88]  David C. Lee,et al.  Defective valvulogenesis in HB‐EGF and TACE‐null mice is associated with aberrant BMP signaling , 2003, The EMBO journal.

[89]  E. Robert.  Epidemiology of congenital heart disease: The Baltimore-Washington Infant Study, 1981–1989 (Perspectives in Pediatric cardiology series, volume 4) , 1994 .

[90]  A. Nagy,et al.  Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. , 2001, The American journal of pathology.

[91]  K. Willecke,et al.  Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system. , 1997, Circulation research.

[92]  Elaine Fuchs,et al.  Sticky Business Orchestrating Cellular Signals at Adherens Junctions , 2003, Cell.

[93]  K. Yutzey,et al.  DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice. , 2004, Developmental biology.

[94]  M Tammi,et al.  Hyaluronan synthases. , 1997, The Journal of biological chemistry.

[95]  R. Markwald,et al.  Structural development of endocardial cushions. , 1977, The American journal of anatomy.

[96]  A. Lassar,et al.  Inhibition of Wnt activity induces heart formation from posterior mesoderm. , 2001, Genes & development.

[97]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[98]  F. Schoen,et al.  NFATc1 Mediates Vascular Endothelial Growth Factor-induced Proliferation of Human Pulmonary Valve Endothelial Cells* , 2003, Journal of Biological Chemistry.

[99]  C. Loffredo.  Epidemiology of cardiovascular malformations: prevalence and risk factors. , 2000, American journal of medical genetics.

[100]  F. Schoen,et al.  Aortic Valve Endothelial Cells Undergo Transforming Growth Factor-β-Mediated and Non-Transforming Growth Factor-β-Mediated Transdifferentiation in Vitro , 2001 .

[101]  R. McCarter,et al.  Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. , 1990, Teratology.